Listen to the conversation our President and CEO, Paul Levesque, had on the National Pharmaceutical Congress (NPC) Podcast, covering Canadian biotech, rare disease policy, and AI as an healthcare accelerator.
Illuminating life at the cellular level
Listen to the conversation our President and CEO, Paul Levesque, had on the National Pharmaceutical Congress (NPC) Podcast, covering Canadian biotech, rare disease policy, and AI as an healthcare accelerator.
Our President and CEO, Paul Levesque, will join industry leaders at the 20th National Pharmaceutical Congress on November 4, 2026 to reflect on two decades of change and explore the future of Canadian pharma.
In La Presse, Paul Lévesque, President and CEO of Celystra Pharma, makes the case for revitalizing Quebec’s pharmaceutical industry in the face of the Trump administration’s “most favoured nation” rule, which threatens Canadians’ access to new medicines. He calls on the government to bring health and economic development together to make Quebec a global leader in life sciences.